Neofordex (Dexamethasone)

Dexamethasone, the active ingredient in Neofordex, is a corticosteroid (glucocorticoid) presented as an oral tablet for oral use. It is employed to reduce inflammation, modulate immune responses, and manage certain cancer‑related complications in adult and pediatric patients. GNH USA supplies Neofordex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Dexamethasone acts on inflammatory and immune pathways, making it useful across several therapeutic areas. - Inflammatory and autoimmune disorders: suppresses inflammation and immune activity to control disease flares. - Allergic reactions: reduces severe allergic inflammation and edema. - Certain malignancies (as part of chemotherapy regimens): mitigates tumor‑associated inflammation and prevents nausea. - Adrenal insufficiency (replacement therapy): provides glucocorticoid activity when endogenous production is inadequate. - Cerebral edema: decreases intracranial pressure caused by swelling.

Dexamethasone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Increased appetite and weight gain - Insomnia or sleep disturbances - Mood swings, anxiety, or mild depression - Elevated blood glucose levels - Gastrointestinal discomfort or ulcer risk - Skin thinning and easy bruising

Serious or Rare Side Effects: - Severe infections due to immune suppression - Adrenal insufficiency on abrupt discontinuation - Psychosis or severe mood disorders - Osteonecrosis of the femoral head - Uncontrolled hypertension or cardiovascular events - Cushingoid appearance with prolonged high‑dose use

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications. - Assess infection risk: screen for active infections before starting. - Monitor blood glucose: adjust diabetic therapy as needed. - Screen for psychiatric symptoms: watch for mood changes or psychosis. - Taper gradually: avoid abrupt cessation to prevent adrenal crisis. - Avoid concurrent high‑dose NSAIDs: increase gastrointestinal bleeding risk. - Store at room temperature: keep in the original pack, protect from moisture.

Dexamethasone can alter the activity of several co‑administered drugs, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase dexamethasone levels. - Live vaccines: risk of uncontrolled infection due to immunosuppression. - Anticoagulants (warfarin): enhanced anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, phenytoin): may reduce efficacy. - Antidiabetic agents: dexamethasone can raise glucose, requiring dose adjustment. - Antihypertensives: possible reduction in blood pressure control. - NSAIDs: additive gastrointestinal irritation.